There are two primary worries about taking a GLP-1 while breastfeeding
Constipation from semaglutide, the active ingredient in both Wegovy and Ozempic, can last a median of 47 days, or about six weeks
2,48 Concern about the risk of pancreatitis increased after GLP-1 receptor agonist indications for use expanded to include cardiovascular and renal protection, obesity and metabolic dysfunctionassociated fatty liver disease (MAFLD
Your medication includes clear dosage information
Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women
During the first few days, many patients experience mild gastrointestinal symptoms such as nausea or mild discomfort as their digestive system becomes accustomed to the medications action